SCHEMBL2361827

SCHEMBL2361827

Nc1nccn1C1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.42
▸ PI4KA P42356 3/20 0.42
▸ PI4K2B Q8TCG2 3/20 0.42
▸ PI4K2A Q9BTU6 3/20 0.42
▸ PI4KB Q9UBF8 3/20 0.42
▸ ADORA3 P0DMS8 2/20 0.42
▸ ADORA1 P30542 2/20 0.42
▸ ADORA2B P29275 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ ABL1 P00519 3/20 0.36
▸ DAPK3 O43293 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ PAK4 O96013 1/20 0.36
▸ LCK P06239 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ CSF1R P07333 1/20 0.36
▸ RET P07949 1/20 0.36
▸ IGF1R P08069 1/20 0.36
▸ FGFR1 P11362 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15543652 0.75 LMNA (0.37) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL16752448 0.75 LMNA (0.37) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL18250691 0.75 KDM4E (0.38) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL4870076 0.73 LMNA (0.39) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL9442396 0.73 PI4KA (0.37) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL11015922 0.73 KDM4E (0.40) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL3237878 0.73 PI4KA (0.37) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL4964108 0.73 KDM4E (0.40) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL2146301 0.72 LMNA (0.38) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL22940000 0.72 LMNA (0.38) ADORA2API4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612149-A1 PYRIDO[2,3-D]PYRIMIDIN-2-AMINE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 — — EP disclosed
US-8377983-B2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors TRANSTECH PHARMA, INC. (US) 2013-02-19 — — US disclosed
WO-2011099832-A2 NOVEL BENZIMIDAZOLE COMPOUND, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CRYSTALGENOMICS, INC. (KR) 2011-08-18 — — WO disclosed
US-7820821-B2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors TRANSTECH PHARMA, INC. (US) 2010-10-26 — — US disclosed
US-20100152170-A1 Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors TRANSTECH PHARMA, INC. (US) 2010-06-17 — — US disclosed
US-20070219235-A1 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors VTVX HOLDINGS I LLC 2007-09-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152170-A1 Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors AURKC, AURKA, AURKB ADORA2A 3105/4885PI4KA 54/4885PI4K2B 120/4885
US-20070219235-A1 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors AURKC, AURKA, AURKB ADORA2A 3105/4885PI4KA 54/4885PI4K2B 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback